In addition, the expression levels of CD36 and CD44 in exosomes were identified via immunoblotting and flow cytometry, and results of this previous study revealed substantial differences in the expression of CD36 and CD44 between healthy individuals and patients with bladder cancer (94). The gene discussed is CD44; the disease is urinary bladder cancer.